• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄较大是否与无其他危险因素的 COVID-19 死亡率相关?对 470034 名参与者的一般人群队列研究。

Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants.

机构信息

Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.

出版信息

PLoS One. 2020 Nov 5;15(11):e0241824. doi: 10.1371/journal.pone.0241824. eCollection 2020.

DOI:10.1371/journal.pone.0241824
PMID:33152008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7644030/
Abstract

INTRODUCTION

Older people have been reported to be at higher risk of COVID-19 mortality. This study explored the factors mediating this association and whether older age was associated with increased mortality risk in the absence of other risk factors.

METHODS

In UK Biobank, a population cohort study, baseline data were linked to COVID-19 deaths. Poisson regression was used to study the association between current age and COVID-19 mortality.

RESULTS

Among eligible participants, 438 (0.09%) died of COVID-19. Current age was associated exponentially with COVID-19 mortality. Overall, participants aged ≥75 years were at 13-fold (95% CI 9.13-17.85) mortality risk compared with those <65 years. Low forced expiratory volume in 1 second, high systolic blood pressure, low handgrip strength, and multiple long-term conditions were significant mediators, and collectively explained 39.3% of their excess risk. The associations between these risk factors and COVID-19 mortality were stronger among older participants. Participants aged ≥75 without additional risk factors were at 4-fold risk (95% CI 1.57-9.96, P = 0.004) compared with all participants aged <65 years.

CONCLUSIONS

Higher COVID-19 mortality among older adults was partially explained by other risk factors. 'Healthy' older adults were at much lower risk. Nonetheless, older age was an independent risk factor for COVID-19 mortality.

摘要

简介

老年人感染 COVID-19 后死亡率更高。本研究探讨了介导这种关联的因素,以及在没有其他危险因素的情况下,年龄增长是否与死亡率升高相关。

方法

在 UK Biobank 这一人群队列研究中,将基线数据与 COVID-19 死亡病例相关联。采用泊松回归分析研究当前年龄与 COVID-19 死亡率之间的关系。

结果

在符合条件的参与者中,有 438 人(0.09%)死于 COVID-19。当前年龄与 COVID-19 死亡率呈指数相关。总体而言,≥75 岁的参与者 COVID-19 死亡率是<65 岁参与者的 13 倍(95%CI 9.13-17.85)。用力呼气量第 1 秒(FEV1)较低、收缩压较高、握力较低以及存在多种慢性疾病是重要的中介因素,共解释了其超额风险的 39.3%。在年龄较大的参与者中,这些危险因素与 COVID-19 死亡率之间的关联更强。≥75 岁且无其他危险因素的参与者与所有<65 岁的参与者相比,风险增加 4 倍(95%CI 1.57-9.96,P = 0.004)。

结论

年龄较大的成年人 COVID-19 死亡率较高部分是由其他危险因素解释的。“健康”的老年人风险较低。尽管如此,年龄仍是 COVID-19 死亡率的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23b1/7644030/e547ee5d81c4/pone.0241824.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23b1/7644030/1a7718ae4e6d/pone.0241824.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23b1/7644030/f18abe681001/pone.0241824.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23b1/7644030/e547ee5d81c4/pone.0241824.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23b1/7644030/1a7718ae4e6d/pone.0241824.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23b1/7644030/f18abe681001/pone.0241824.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23b1/7644030/e547ee5d81c4/pone.0241824.g003.jpg

相似文献

1
Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants.年龄较大是否与无其他危险因素的 COVID-19 死亡率相关?对 470034 名参与者的一般人群队列研究。
PLoS One. 2020 Nov 5;15(11):e0241824. doi: 10.1371/journal.pone.0241824. eCollection 2020.
2
Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort.英国生物库社区队列中预测 COVID-19 和死亡率的预先存在的合并症。
J Gerontol A Biol Sci Med Sci. 2020 Oct 15;75(11):2224-2230. doi: 10.1093/gerona/glaa183.
3
Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank.比较两种不同的衰弱测量方法与 COVID-19 住院或死亡风险的关系:来自英国生物银行的研究结果。
BMC Med. 2020 Nov 10;18(1):355. doi: 10.1186/s12916-020-01822-4.
4
Association of frailty with mortality in older inpatients with Covid-19: a cohort study.衰弱与 COVID-19 老年住院患者死亡率的关联:一项队列研究。
Age Ageing. 2020 Oct 23;49(6):915-922. doi: 10.1093/ageing/afaa184.
5
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study.英格兰 1 型和 2 型糖尿病患者 COVID-19 相关死亡率的风险因素:一项基于人群的队列研究。
Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833. doi: 10.1016/S2213-8587(20)30271-0. Epub 2020 Aug 13.
6
Risk Factors for Mortality in 244 Older Adults With COVID-19 in Wuhan, China: A Retrospective Study.中国武汉 244 例老年 COVID-19 患者死亡危险因素的回顾性研究。
J Am Geriatr Soc. 2020 Jun;68(6):E19-E23. doi: 10.1111/jgs.16533. Epub 2020 May 12.
7
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
8
Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.美国 10131 名 SARS-CoV-2 感染退伍军人住院、机械通气或死亡的危险因素。
JAMA Netw Open. 2020 Sep 1;3(9):e2022310. doi: 10.1001/jamanetworkopen.2020.22310.
9
Predictors of Mortality in Adults Admitted with COVID-19: Retrospective Cohort Study from New York City.COVID-19 成年住院患者死亡率的预测因素:来自纽约市的回顾性队列研究。
West J Emerg Med. 2020 Jul 8;21(4):779-784. doi: 10.5811/westjem.2020.6.47919.
10
Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.美国 31461 例 COVID-19 成年人死亡相关合并症:一项联合电子病历分析。
PLoS Med. 2020 Sep 10;17(9):e1003321. doi: 10.1371/journal.pmed.1003321. eCollection 2020 Sep.

引用本文的文献

1
Global, Regional, and National Burden of Pressure Ulcers From 1990 to 2021 and Projections Over the Next Decade: Results From the 2021 GBD Study.1990年至2021年全球、区域和国家压力性损伤负担及未来十年预测:2021年全球疾病负担研究结果
Wound Repair Regen. 2025 Jul-Aug;33(4):e70064. doi: 10.1111/wrr.70064.
2
Individual, household structure, and socioeconomic predictors of COVID-19 testing and vaccination outcomes: a whole population linked data analysis.新冠病毒检测与疫苗接种结果的个体、家庭结构及社会经济预测因素:一项全人群关联数据分析
Int J Popul Data Sci. 2025 May 27;10(1):2930. doi: 10.23889/ijpds.v10i1.2930. eCollection 2025.
3

本文引用的文献

1
Age Alone is not Adequate to Determine Health-care Resource Allocation During the COVID-19 Pandemic.仅年龄不足以决定新冠疫情期间的医疗资源分配。
Can Geriatr J. 2020 Mar 1;23(1):152-154. doi: 10.5770/cgj.23.452. eCollection 2020 Mar.
2
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.危重症和死亡 COVID-19 病例的风险因素:系统文献回顾和荟萃分析。
J Infect. 2020 Aug;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021. Epub 2020 Apr 23.
3
Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms.
Association of Cancer History with COVID-19 Risk and Outcomes among Older Postmenopausal Women: Results from the Women's Health Initiative.
绝经后老年女性癌症病史与 COVID-19 风险及预后的关联:妇女健康倡议的结果
Cancer Epidemiol Biomarkers Prev. 2025 Aug 1;34(8):1286-1294. doi: 10.1158/1055-9965.EPI-24-1682.
4
Exploring the biological mechanisms of severe COVID-19 in the elderly: Insights from an aged mouse model.探索老年人中重症新型冠状病毒肺炎的生物学机制:来自老年小鼠模型的见解
Virulence. 2025 Dec;16(1):2487671. doi: 10.1080/21505594.2025.2487671. Epub 2025 Apr 14.
5
Depressive Symptom Change Patterns during the COVID-19 Pandemic and Their Impact on Psychiatric Treatment Seeking: A 24-Month Observational Study of the Adult Population.新冠疫情期间抑郁症状变化模式及其对寻求精神科治疗的影响:一项针对成年人群的24个月观察性研究
Depress Anxiety. 2024 Aug 5;2024:1272738. doi: 10.1155/2024/1272738. eCollection 2024.
6
Effect of antecedent B-cell depletion therapy for patients hospitalized with COVID-19 within a single health system: a propensity score analysis.单一医疗系统中接受过前期B细胞耗竭疗法的COVID-19住院患者的疗效:一项倾向评分分析。
Sci Rep. 2025 Mar 20;15(1):9647. doi: 10.1038/s41598-025-94024-y.
7
A longitudinal cohort study on dispensed analgesic and psychotropic medications in older adults before, during, and after the COVID-19 pandemic: the HUNT study.一项关于老年人在2019年冠状病毒病大流行之前、期间和之后所使用的镇痛和精神类药物的纵向队列研究:HUNT研究
BMC Geriatr. 2025 Feb 7;25(1):85. doi: 10.1186/s12877-025-05745-8.
8
Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19.血液绝对淋巴细胞计数及其变化轨迹对于理解重症新型冠状病毒肺炎至关重要。
BMC Infect Dis. 2025 Jan 15;25(1):67. doi: 10.1186/s12879-024-10428-7.
9
Priorities and challenges in social and healthcare policies for older people living in the Mediterranean basin: A Delphi panel study.地中海盆地老年人社会和医疗保健政策的优先事项和挑战:德尔菲小组研究。
BMC Geriatr. 2024 Oct 18;24(1):845. doi: 10.1186/s12877-024-05430-2.
10
Probiotics for preventing or treating COVID-19; a systematic review of research evidence and meta-analyses of efficacy for preventing death, severe disease, or disease progression.用于预防或治疗新型冠状病毒肺炎的益生菌:研究证据的系统评价及预防死亡、重症或疾病进展疗效的荟萃分析
Wellcome Open Res. 2022 Dec 5;7:292. doi: 10.12688/wellcomeopenres.18526.1. eCollection 2022.
肥胖是重症 COVID-19 感染的危险因素:多种潜在机制。
Circulation. 2020 Jul 7;142(1):4-6. doi: 10.1161/CIRCULATIONAHA.120.047659. Epub 2020 Apr 22.
4
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
5
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.2020 年 3 月 1 日至 30 日,14 个州住院的经实验室确诊的 2019 冠状病毒病患者的住院率和特征 - COVID-NET。
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3.
6
SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes.老年人中的 SARS-CoV-2 和 COVID-19:关于发病机制、免疫反应和结局,我们可能会有哪些预期。
Geroscience. 2020 Apr;42(2):505-514. doi: 10.1007/s11357-020-00186-0. Epub 2020 Apr 10.
7
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响:一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
8
Covid-19: risk factors for severe disease and death.新冠病毒病:重症和死亡的风险因素
BMJ. 2020 Mar 26;368:m1198. doi: 10.1136/bmj.m1198.
9
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
10
COVID-19: combining antiviral and anti-inflammatory treatments.2019冠状病毒病:联合抗病毒与抗炎治疗
Lancet Infect Dis. 2020 Apr;20(4):400-402. doi: 10.1016/S1473-3099(20)30132-8. Epub 2020 Feb 27.